Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Oxytocin

EU orphan designation number: EU/3/14/1302   
Active ingredient: Oxytocin
Indication: Treatment of Prader-Willi syndrome
Sponsor: Maïthé Tauber
Hopital des Enfants, 330 av de Grande Bretagne, TSA70034, 31059 Toulouse Cedex 9, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/07/2014 Orphan designation EMA/OD/054/14 (2014)5527 of 29/07/2014